Quantitative assessment of cardiac electrical heterogeneity in patients with polycystic ovary syndrome by transmural dispersion of repolarization and atrial electromechanical coupling

Tokatli, A.; Yiginer, O.
December 2015
European Review for Medical & Pharmacological Sciences;Dec2015, Vol. 19 Issue 24, p4688
Academic Journal
Letter to the Editor
A letter to the editor is presented in response to the article "Two Markers in Predicting the Cardiovascular Events in Patients With Polycystic Ovary Syndrome: Increased P-Wave and QT Dispersion" by S. Akdag, N. Cim, R. Yildizhan and colleagues in the September 19, 2015 issue.


Related Articles

  • New consensus statement on assessment of CV risk, prevention in women with PCOS. Brannon, Matthew // Endocrine Today;Jun2010 Supplement, Vol. 8, p13 

    The article emphasizes the need to assess the risk of cardiovascular disease in women with polycystic ovary syndrome (PCOS).

  • Hawthorn berries ethanolic extract lowered polycystic ovarian syndrome-elevated testosterone level and improved the altered ovaries structure. Alijanpour, K.; Malekinejad, H.; Razi, M // Iranian Journal of Reproductive Medicine;Jun2014 Supplement, Vol. 12, p102 

    Introduction: Polycystic ovarian syndrome (PCOS) is the most common endocrinopathy seen in women. Hawthorn extract is traditionally used for treating cardiovascular diseases and plasma cholesterol lowering. Various constituents including flavonoids with biological activities including free...

  • Insulin-like growth factor 1, liver enzymes, and insulin resistance in patients with PCOS and hirsutism. ÇAKIR, Evrim; TOPALOĞLU, Oya; BOZKURT, Nujen ÇOLAK; BAYRAKTAR, Başak KARBEK; GÜNGÜNES, Aşkin; ARSLAN, Müyesser SAYKI; ÜNSAL, İlknur ÖZTÜRK; TUTAL, Esra; UÇAN, Bekir; DELİBAŞI, Tuncay // Turkish Journal of Medical Sciences;2014, Vol. 44 Issue 5, p781 

    Aim: Hyperinsulinemia and insulin resistance are commonly seen in patients with hirsutism and polycystic ovary syndrome (PCOS), and are associated with cardiovascular disease risk. However, it is not yet known whether insulin-like growth factor I (IGF-I) and alanine transaminase (ALT) produced...

  • Assessment of atrial electromechanical interval and P wave dispersion in patients with polycystic ovary syndrome. Bayı, Pınar Türker; Güray, Ümit; Duyuler, Serkan; Demirkan, Burcu; Kayaalp, Oya; Kanat, Selçuk; Güray, Yeşim // Anatolian Journal of Cardiology / Anadolu Kardiyoloji Dergisi;Feb2016, Vol. 16 Issue 2, p100 

    Objective: Polycystic ovary syndrome (PCOS) is associated with increased cardiovascular risk, including ischemic stroke. Prolonged atrial electromechanical interval (EMI) is related to increased atrial fibrillation (AF) risk. The aim of the study is to evaluate atrial EMI and...

  • Insulin Resistance and Lipid Accumulation Product in Correlation to Body Mass Index in Women with Polycystic Ovary Syndrome. Godinjak, Amina; Godinjak, Zulfo; Burekovic, Azra; Surkovic, Ismana; Dizdarevic-Bostandzic, Amela; Velija-Asimi, Zelija // Medical Archives / Medicinski Arhiv;2012, Vol. 66 Issue 6, p409 

    Introduction: Women with Polycystic Ovary Syndrome (PCOS) are at increased risk for cardiovascular morbidity and metabolic disorders including: dyslipidaemia, hypertension, insulin resistance, gestational diabetes, type 2 diabetes, systemic inflammation and endothelial dysfunction. The...

  • Endothelial Progenitor Cell Dysfunction in Polycystic Ovary Syndrome: Implications for The Genesis of Cardiovascular Diseases. Yu-Hsun Kao; Wan-Chun Chiu; Ming-I Hsu; Yi-Jen Chen // International Journal of Fertility & Sterility;Winter2013, Vol. 6 Issue 4, p208 

    Polycystic ovary syndrome (PCOS), the most common endocrine disorder affecting women of reproductive age, is characterized by hyperandrogenism and insulin resistance. Women with PCOS have a higher risk for cardiovascular diseases (CVDs) and endothelial dysfunction. The mechanisms underlying...

  • Microvascular dysfunction in women with polycystic ovary syndrome. K. Lakhani; A. Leonard; A.M. Seifalian; P. Hardiman // Human Reproduction;Nov2005, Vol. 20 Issue 11, p3219 

    BACKGROUND: Polycystic ovary syndrome (PCOS) is associated with multiple cardiovascular risk factors and an increased prevalence of arterial dysfunction. However, microvascular dysfunction in PCOS has not been assessed. METHODS: Subjects comprised 12 women with PCOS and 12 age-matched controls...

  • Black PCOS Women Have Higher Risk for Metabolic Syndrome and CVD than White PCOS Women.  // Fertility Weekly;5/12/2014, p7 

    The article discusses a study which aims to determine the risk of cardiovascular disease (CVD) and prevalence of metabolic syndrome (MetSyn) on African American and White American adolescents and adult women with polycystic ovary syndrome (PCOS). Results show higher prevalence of MetSyn among...

  • Cardiovascular disease risk characteristics of the main polycystic ovary syndrome phenotypes. Dilbaz, Berna; Özkaya, Enis; Cinar, Mehmet; Cakir, Evrim; Dilbaz, Serdar // Endocrine (1355008X);Jun2011, Vol. 39 Issue 3, p272 

    The aim of this article was to evaluate the clinical, endocrine, and cardiovascular disease risk profile differences among main polycystic ovary syndrome (PCOS) phenotypes. One hundred and thirty-nine consecutive women were included in the study. Body mass index (BMI), serum follicle stimulating...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics